Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05997615 |
| Title | Safety, Pharmacokinetics, and Preliminary Efficacy of AMX-500 in Metastatic Castration Resistant Prostate Cancer (mCRPC) |
| Recruitment | Recruiting |
| Gender | male |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Amunix, a Sanofi Company |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | GBR | ESP | AUS |